, 10 , 14 ] Semarion's semacyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance scalability and efficiency in drug discovery. Bespoke, integrated automation platforms enable scientists to use their expertise to design and adapt systems to meet their specific workflow needs
Considering data, technology, and organisational requirements [15 ] Live cell cultures that replicate in vivo physiological conditions enable more reliable predictions about the safety and efficacy of drugs Cellular in vitro assays are routinely used in early drug discovery to identify potential drug candidate molecules.
